Efficacy and safety of a quadrivalent influenza vaccine in children aged 6-35 months: A global, multiseasonal, controlled, randomized Phase III study

Anamnestic immune response and safety of an inactivated quadrivalent influenza vaccine in primed versus vaccine-naïve children

Claeys, C
Chandrasekaran, V
García-Sicilia, J
Prymula, R
Díez-Domingo, J
Brzostek, J
Marès-Bermúdez, J
Martinón-Torres, F
Pollard, AJ
Růžková, R
Martinez, AC
Ulied, A
Valdivieso, MM
Faust, SN
Snape, MD
Friel, D
Ollinger, T
Soni, J
Schuind, A
Li, P
Innis, BL
Jain, VK

October 2018

Background: It has not yet been demonstrated whether two doses of inactivated quadrivalent influenza...

Cold-Adapted Influenza Vaccine in an Indicated Population Aged 5–49 Years

Colin Hessel
Iksung Cho
Paul M. Mendelman

October 2016

(See the editorial commentary by Wright on pages 928–9) Background. Three important studies have sup...

Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity

Ambrose, Christopher S.
Wu, Xionghua
Caspard, Herve
Belshe, Robert B.

September 2014

AbstractA recent study of inactivated influenza vaccine (IIV) in children aged 3–8 years demonstrate...

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis

Xia Wei (2063044)
Xue Tan (2994324)
Qinghu Guan (14233802)
Ruizhi Zhang (752030)
Shiguang Lei (11216043)
Shaofeng Wei (10927188)

October 2023

Evidence of the immunogenicity and safety of quadrivalent inactivated influenza vaccine in children ...

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

Jain, Varsha K.
Rivera, Luis
Zaman, Khalequ
Espos, Jr., Roberto A.
Sirivichayakul, Chukiat
Quiambao, Beatriz P.
Rivera-Medina, Doris M.
Kerdpanich, Pirunghul
Ceyhan, Mehmet
Dinleyici, Ener C.
Cravioto, Alejandro
Yunus, Mohammed
Chanthavanich, Pornthep
Limkittikul, Kriengsak
Kurugol, Zafer
Alhan, Emre
Caplanusi, Adrian
Durviaux, Serge
Boutet, Philippe
Ofori-Anyinam, Opokua
Chandrasekaran, Vijayalakshmi
Dbaibo, Ghassan
Innis, Bruce L.

January 2013

Background: Commonly used trivalent vaccines contain one influenza B virus lineage and may be ineffe...

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6–35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

Pepin, Stephanie
Dupuy, Martin
Borja-Tabora, Charissa Fay Corazon
Montellano, May
Bravo, Lulu
Santos, Jaime
de Castro, Jo Anne
Rivera-Medina, Doris Maribel
Cutland, Clare
Ariza, Miguel
Diez-Domingo, Javier
Gonzalez, Celia Diaz
Martinón-Torres, Federico
Papadopoulou-Alataki, Efimia
Theodoriadou, Maria
Kazek-Duret, Marie Pierre
Gurunathan, Sanjay
De Bruijn, Iris

March 2019

Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

Claeys, Carine
Zaman, Khalequ
Dbaibo, Ghassan
Li, Ping
Izu, Allen
Kosalaraksa, Pope
Rivera, Luis
Acosta, Beatriz
Arroba Basanta, Maria Luisa
Aziz, Asma
Cabanero, Miguel Angel
Chandrashekaran, Vijayalakshmi
Corsaro, Bartholomew
Cousin, Luis
Diaz, Adolfo
Diez-Domingo, Javier
Dinleyici, Ener Cagri
Faust, Saul N
Friel, Damien
Garcia-Sicilia, Jose
Gomez-Go, Grace D
Antoinette Gonzales, Maria Liza
Hughes, Stephen M
Jackowska, Teresa
Kant, Shashi
Lucero, Marilla
Malvaux, Ludovic
Mares Bermudez, Josep
Martinon-Torres, Federico
Miranda, Mariano
Montellano, May
Peix Sambola, Maria Amor
Prymula, Roman
Puthanakit, Thanyawee
Ruzkova, Renata
Sadowska-Krawczenko, Iwona
Salamanca de la Cueva, Ignacio
Sokal, Etienne
Soni, Jyoti
Szymanski, Henryk
Ulied, Angels
Schuind, Anne
Jain, Varsha K
Innis, Bruce L
Acostas, Beatriz
Amanullah, Arshad
Ariza, Miguel
Arroba Basanta, Maria Luisa
Aziz, Asma
Bautista, Milagros
Bavdekar, Ashish
Bodalia, Bhavesh
Bravo, Lulu C
Brzostek, Jerzy
Cabanero, Miguel Angel
Caldwell, Ian
Carmona, Alfonso
Chandrashekaran, Vijayalakshmi
Claeys, Carine
Corsaro, Bartholomew
Cousin, Luis
Danier, Jasur
Dbaibo, Ghassan
Diaz Cirujano, Ana Isabel
Diaz, Adolfo
Diez-Domingo, Javier
Dinleyici, Ener Cagri
Docx, Martine
Drazan, Daniel
Faust, Saul N
Galaj, Andrzej
Garcia Rodriguez, Fermin
Garcia-Sicilia, Jose
Gonzales, Maria Liza Antoinette
Gomez-Go, Grace D
Gooding, Trevor
Hacimustafaoglu, Mustafa
Heath, Paul
Heaton, Paul
Hughes, Stephen M
Innis, Bruce L
Izu, Allen
Jackowska, Teresa
Jain, Varsha K
Kant, Shashi
Kosalaraksa, Pope
Lalwani, Sanjay
Langlands, Jennifer
Li, Ping
Logghe, Karl
Lucero, Marilla
Malvaux, Ludovic
Mantyka, Jolanta
Mares Bermudez, Josep
Martinon-Torres, Federico
McNally, Damien
Miszczak-Kowalska, Edyta
Montellano, May
Peix Sambola, Maria Amor
Prymula, Roman
Puthanakit, Thanyawee
Rivera, Luis
Royal, Simon
Ruzkova, Renata
Sablan, Benjamin
Sadowska-Krawczenko, Iwona
Salamanca de la Cueva, Ignacio
Schuind, Anne
Snape, Matthew
Soni, Jyoti
Tomlinson, Richard
Ulied, Angels
Verghote, Marc
Vertruyen, Andre
Wheeler, Marie
Zaman, Khalequ

January 2018

BACKGROUND: Despite the importance of vaccinating children younger than 5 years, few studies evaluat...

Vaccine for prevention of mild and moderate-to-severe influenza in children

Jain V.K.
Rivera L.
Zaman K.
Espos Jr. R.A.
Sirivichayakul C.
Quiambao B.P.
Rivera-Medina D.M.

January 2013

BACKGROUND: Commonly used trivalent vaccines contain one influenza B virus lineage and may be ineffe...

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

Langley, Joanne M.
黃立民

February 2014

Background. Mismatch between circulating influenza B viruses (Yamagata and Victoria lineages) and va...

Influenza vaccine efficacy in young children attending childcare: a randomised controlled trial

Li-Kim-Moy, Jean P.
Yin, Jiehui K.
Heron, Leon
Leask, Julie
Lambert, Stephen B.
Nissen, Michael
Sloots, Theo
Booy, Robert

January 2017

AimInfluenza causes a substantial burden in young children. Vaccine efficacy (VE) data are limited i...

Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35Months of Age in 2012–2013: A Randomized, Double-Blind,

Clinical Trial
Varsha K. Jain

January 2014

Background. Influenza attack rates are high in 6- to 35-month-old children; vaccines containing both...

Clinical presentation of influenza in children 6 to 35 months of age: findings from a randomized clinical trial of inactivated quadrivalent influenza vaccine

Danier, J.
Rivera, L.
Claeys, C
Dbaibo, G.
Jain, V.K.
Kosalarksa, P.
Woo, W.
Yanni, E.
Zaman, K.
Acosta, B.
Amanullah, A.
Ariza, M.
Arroba Basanta, M.L.
Bavdekar, Ashish
Carmona, A.
Cousin, L.
Diaz, L.
Diez-Domingo, J
Dinleyici, E.C.
Faust, S.
Garcia-Sicilia, J.
Gomez-Go, G.D.
Gonzales, M.L.A.
Hacimustafaoglu, M.
Hughes, S.M.
Izu, A.
Jackowska, T.
Kant, S.
Lucero, M.
Mares Bermudez, J.
Martinon-Torres, F.
Montellano, M.
Prymula, R.
Puthanakit, T.
Ruzkova, R.
Sadowska-Krawczenko, I.
Soni, J
Szymanski, H.
Ulied, A.
Schuind, A.

August 2019

Background: In an exploratory analysis of an inactivated quadrivalent influenza vaccine (IIV4) trial...

Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial

Robyn Hartvickson
Marilou Cruz
John Ervin
Donald Brandon
Eduardo Forleo-Neto
Alemnew F. Dagnew
Richa Chandra
Kelly Lindert
Ahmed Abdul Mateen

December 2015

Objectives: The safety and immunogenicity of mammalian cell-derived quadrivalent influenza vaccine (...

The immunogenicity and safety of a single 0.5mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months : Data from a randomized, Phase III study

S. Esposito
P. Marchisio
V. Montinaro
S. Bianchini
G.J. Weverling
E. Pariani
A. Amendola
V. Fabiano
V. Pivetti
A. Zanetti
G.V. Zuccotti

November 2012

This study evaluated the immunogenicity, safety and tolerability of a single 0.5mL dose of the seaso...

Adjuvanted versus nonadjuvanted influenza vaccines in young children: comparing results from recent clinical trials

Wijnans, E.G. (Leonoor)
Weibel, D.M. (Daniel)
Sturkenboom, M.C.J.M. (Miriam)

April 2013

A relatively high burden of influenza is experienced by young children. In order to successfully tac...

Anamnestic immune response and safety of an inactivated quadrivalent influenza vaccine in primed versus vaccine-naïve children

Claeys, C
Chandrasekaran, V
García-Sicilia, J
Prymula, R
Díez-Domingo, J
Brzostek, J
Marès-Bermúdez, J
Martinón-Torres, F
Pollard, AJ
Růžková, R
Martinez, AC
Ulied, A
Valdivieso, MM
Faust, SN
Snape, MD
Friel, D
Ollinger, T
Soni, J
Schuind, A
Li, P
Innis, BL
Jain, VK

October 2018

Background: It has not yet been demonstrated whether two doses of inactivated quadrivalent influenza...

Cold-Adapted Influenza Vaccine in an Indicated Population Aged 5–49 Years

Colin Hessel
Iksung Cho
Paul M. Mendelman

October 2016

(See the editorial commentary by Wright on pages 928–9) Background. Three important studies have sup...

Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity

Ambrose, Christopher S.
Wu, Xionghua
Caspard, Herve
Belshe, Robert B.

September 2014

AbstractA recent study of inactivated influenza vaccine (IIV) in children aged 3–8 years demonstrate...

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis

Xia Wei (2063044)
Xue Tan (2994324)
Qinghu Guan (14233802)
Ruizhi Zhang (752030)
Shiguang Lei (11216043)
Shaofeng Wei (10927188)

October 2023

Evidence of the immunogenicity and safety of quadrivalent inactivated influenza vaccine in children ...

Vaccine for Prevention of Mild and Moderate-to-Severe Influenza in Children

Jain, Varsha K.
Rivera, Luis
Zaman, Khalequ
Espos, Jr., Roberto A.
Sirivichayakul, Chukiat
Quiambao, Beatriz P.
Rivera-Medina, Doris M.
Kerdpanich, Pirunghul
Ceyhan, Mehmet
Dinleyici, Ener C.
Cravioto, Alejandro
Yunus, Mohammed
Chanthavanich, Pornthep
Limkittikul, Kriengsak
Kurugol, Zafer
Alhan, Emre
Caplanusi, Adrian
Durviaux, Serge
Boutet, Philippe
Ofori-Anyinam, Opokua
Chandrasekaran, Vijayalakshmi
Dbaibo, Ghassan
Innis, Bruce L.

January 2013

Background: Commonly used trivalent vaccines contain one influenza B virus lineage and may be ineffe...

Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6–35 months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres

Pepin, Stephanie
Dupuy, Martin
Borja-Tabora, Charissa Fay Corazon
Montellano, May
Bravo, Lulu
Santos, Jaime
de Castro, Jo Anne
Rivera-Medina, Doris Maribel
Cutland, Clare
Ariza, Miguel
Diez-Domingo, Javier
Gonzalez, Celia Diaz
Martinón-Torres, Federico
Papadopoulou-Alataki, Efimia
Theodoriadou, Maria
Kazek-Duret, Marie Pierre
Gurunathan, Sanjay
De Bruijn, Iris

March 2019

Prevention of vaccine-matched and mismatched influenza in children aged 6–35 months: a multinational randomised trial across five influenza seasons

Claeys, Carine
Zaman, Khalequ
Dbaibo, Ghassan
Li, Ping
Izu, Allen
Kosalaraksa, Pope
Rivera, Luis
Acosta, Beatriz
Arroba Basanta, Maria Luisa
Aziz, Asma
Cabanero, Miguel Angel
Chandrashekaran, Vijayalakshmi
Corsaro, Bartholomew
Cousin, Luis
Diaz, Adolfo
Diez-Domingo, Javier
Dinleyici, Ener Cagri
Faust, Saul N
Friel, Damien
Garcia-Sicilia, Jose
Gomez-Go, Grace D
Antoinette Gonzales, Maria Liza
Hughes, Stephen M
Jackowska, Teresa
Kant, Shashi
Lucero, Marilla
Malvaux, Ludovic
Mares Bermudez, Josep
Martinon-Torres, Federico
Miranda, Mariano
Montellano, May
Peix Sambola, Maria Amor
Prymula, Roman
Puthanakit, Thanyawee
Ruzkova, Renata
Sadowska-Krawczenko, Iwona
Salamanca de la Cueva, Ignacio
Sokal, Etienne
Soni, Jyoti
Szymanski, Henryk
Ulied, Angels
Schuind, Anne
Jain, Varsha K
Innis, Bruce L
Acostas, Beatriz
Amanullah, Arshad
Ariza, Miguel
Arroba Basanta, Maria Luisa
Aziz, Asma
Bautista, Milagros
Bavdekar, Ashish
Bodalia, Bhavesh
Bravo, Lulu C
Brzostek, Jerzy
Cabanero, Miguel Angel
Caldwell, Ian
Carmona, Alfonso
Chandrashekaran, Vijayalakshmi
Claeys, Carine
Corsaro, Bartholomew
Cousin, Luis
Danier, Jasur
Dbaibo, Ghassan
Diaz Cirujano, Ana Isabel
Diaz, Adolfo
Diez-Domingo, Javier
Dinleyici, Ener Cagri
Docx, Martine
Drazan, Daniel
Faust, Saul N
Galaj, Andrzej
Garcia Rodriguez, Fermin
Garcia-Sicilia, Jose
Gonzales, Maria Liza Antoinette
Gomez-Go, Grace D
Gooding, Trevor
Hacimustafaoglu, Mustafa
Heath, Paul
Heaton, Paul
Hughes, Stephen M
Innis, Bruce L
Izu, Allen
Jackowska, Teresa
Jain, Varsha K
Kant, Shashi
Kosalaraksa, Pope
Lalwani, Sanjay
Langlands, Jennifer
Li, Ping
Logghe, Karl
Lucero, Marilla
Malvaux, Ludovic
Mantyka, Jolanta
Mares Bermudez, Josep
Martinon-Torres, Federico
McNally, Damien
Miszczak-Kowalska, Edyta
Montellano, May
Peix Sambola, Maria Amor
Prymula, Roman
Puthanakit, Thanyawee
Rivera, Luis
Royal, Simon
Ruzkova, Renata
Sablan, Benjamin
Sadowska-Krawczenko, Iwona
Salamanca de la Cueva, Ignacio
Schuind, Anne
Snape, Matthew
Soni, Jyoti
Tomlinson, Richard
Ulied, Angels
Verghote, Marc
Vertruyen, Andre
Wheeler, Marie
Zaman, Khalequ

January 2018

BACKGROUND: Despite the importance of vaccinating children younger than 5 years, few studies evaluat...

Vaccine for prevention of mild and moderate-to-severe influenza in children

Jain V.K.
Rivera L.
Zaman K.
Espos Jr. R.A.
Sirivichayakul C.
Quiambao B.P.
Rivera-Medina D.M.

January 2013

BACKGROUND: Commonly used trivalent vaccines contain one influenza B virus lineage and may be ineffe...

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

Langley, Joanne M.
黃立民

February 2014

Background. Mismatch between circulating influenza B viruses (Yamagata and Victoria lineages) and va...

Influenza vaccine efficacy in young children attending childcare: a randomised controlled trial

Li-Kim-Moy, Jean P.
Yin, Jiehui K.
Heron, Leon
Leask, Julie
Lambert, Stephen B.
Nissen, Michael
Sloots, Theo
Booy, Robert

January 2017

AimInfluenza causes a substantial burden in young children. Vaccine efficacy (VE) data are limited i...

Immunogenicity and Reactogenicity of an Inactivated Quadrivalent Influenza Vaccine Administered Intramuscularly to Children 6 to 35Months of Age in 2012–2013: A Randomized, Double-Blind,

Clinical Trial
Varsha K. Jain

January 2014

Background. Influenza attack rates are high in 6- to 35-month-old children; vaccines containing both...

Clinical presentation of influenza in children 6 to 35 months of age: findings from a randomized clinical trial of inactivated quadrivalent influenza vaccine

Danier, J.
Rivera, L.
Claeys, C
Dbaibo, G.
Jain, V.K.
Kosalarksa, P.
Woo, W.
Yanni, E.
Zaman, K.
Acosta, B.
Amanullah, A.
Ariza, M.
Arroba Basanta, M.L.
Bavdekar, Ashish
Carmona, A.
Cousin, L.
Diaz, L.
Diez-Domingo, J
Dinleyici, E.C.
Faust, S.
Garcia-Sicilia, J.
Gomez-Go, G.D.
Gonzales, M.L.A.
Hacimustafaoglu, M.
Hughes, S.M.
Izu, A.
Jackowska, T.
Kant, S.
Lucero, M.
Mares Bermudez, J.
Martinon-Torres, F.
Montellano, M.
Prymula, R.
Puthanakit, T.
Ruzkova, R.
Sadowska-Krawczenko, I.
Soni, J
Szymanski, H.
Ulied, A.
Schuind, A.

August 2019

Background: In an exploratory analysis of an inactivated quadrivalent influenza vaccine (IIV4) trial...

Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial

Robyn Hartvickson
Marilou Cruz
John Ervin
Donald Brandon
Eduardo Forleo-Neto
Alemnew F. Dagnew
Richa Chandra
Kelly Lindert
Ahmed Abdul Mateen

December 2015

Objectives: The safety and immunogenicity of mammalian cell-derived quadrivalent influenza vaccine (...

The immunogenicity and safety of a single 0.5mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months : Data from a randomized, Phase III study

S. Esposito
P. Marchisio
V. Montinaro
S. Bianchini
G.J. Weverling
E. Pariani
A. Amendola
V. Fabiano
V. Pivetti
A. Zanetti
G.V. Zuccotti

November 2012

This study evaluated the immunogenicity, safety and tolerability of a single 0.5mL dose of the seaso...

Adjuvanted versus nonadjuvanted influenza vaccines in young children: comparing results from recent clinical trials

Wijnans, E.G. (Leonoor)
Weibel, D.M. (Daniel)
Sturkenboom, M.C.J.M. (Miriam)

April 2013

A relatively high burden of influenza is experienced by young children. In order to successfully tac...

Anamnestic immune response and safety of an inactivated quadrivalent influenza vaccine in primed versus vaccine-naïve children

Claeys, C
Chandrasekaran, V
García-Sicilia, J
Prymula, R
Díez-Domingo, J
Brzostek, J
Marès-Bermúdez, J
Martinón-Torres, F
Pollard, AJ
Růžková, R
Martinez, AC
Ulied, A
Valdivieso, MM
Faust, SN
Snape, MD
Friel, D
Ollinger, T
Soni, J
Schuind, A
Li, P
Innis, BL
Jain, VK

October 2018

Background: It has not yet been demonstrated whether two doses of inactivated quadrivalent influenza...

Cold-Adapted Influenza Vaccine in an Indicated Population Aged 5–49 Years

Colin Hessel
Iksung Cho
Paul M. Mendelman

October 2016

(See the editorial commentary by Wright on pages 928–9) Background. Three important studies have sup...

Efficacy of live attenuated influenza vaccine against influenza illness in children as a function of illness severity

Ambrose, Christopher S.
Wu, Xionghua
Caspard, Herve
Belshe, Robert B.

September 2014

AbstractA recent study of inactivated influenza vaccine (IIV) in children aged 3–8 years demonstrate...

Efficacy and safety of a quadrivalent influenza vaccine in children aged 6-35 months: A global, multiseasonal, controlled, randomized Phase III study

Abstract

Extracted data

Efficacy and safety of a quadrivalent influenza vaccine in children aged 6-35 months: A global, multiseasonal, controlled, randomized Phase III study

Abstract

Extracted data

Related items

Related items